These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37382044)

  • 1. Reply to the letter "skin manifestations following anti-COVID-19 vaccination: A multicentric study from Turkey: Correspondence".
    Topal IO; Karadağ AS
    J Cosmet Dermatol; 2024 Jan; 23(1):7. PubMed ID: 37382044
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous manifestations following COVID-19 vaccination: a multicentric descriptive cohort.
    Massip E; Marcant P; Font G; Faiz S; Duvert-Lehembre S; Alcaraz I; Vermersch-Langlin A; Véron M; Macaire C; Faure K; Vuotto F; Staumont-Sallé D; Dezoteux F
    J Eur Acad Dermatol Venereol; 2022 Apr; 36(4):e253-e255. PubMed ID: 34927749
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to the letter "cutaneous adverse events following the inactivated and mRNA COVID-19 vaccines: Correspondence".
    Bostan E; Yel B; Karaduman A
    J Cosmet Dermatol; 2022 Dec; 21(12):7230. PubMed ID: 36177512
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous reactions after COVID-19 vaccination in Turkey: Questions and answers.
    Cebeci Kahraman F; Temiz SA
    J Cosmet Dermatol; 2023 Aug; 22(8):2368-2369. PubMed ID: 36891626
    [No Abstract]   [Full Text] [Related]  

  • 5. Study of covid-19 vaccine-related cutaneous adverse events following immunization and establishing a causal association.
    Sharma R
    J Eur Acad Dermatol Venereol; 2023 May; 37(5):e576-e577. PubMed ID: 36662656
    [No Abstract]   [Full Text] [Related]  

  • 6. Annular cutaneous sarcoidosis following COVID-19 vaccination.
    Ramos J; Silva A; Roda Â; Alves J
    J Eur Acad Dermatol Venereol; 2024 May; 38(5):e377-e379. PubMed ID: 38299691
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous manifestations following SARS-CoV-2 vaccination.
    Majewska L
    Dermatol Ther; 2022 Nov; 35(11):e15784. PubMed ID: 36001633
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter reply "John Stuart Mill and COVID-19 vaccination".
    Chervenak FA; Grünebaum A; Moreno JD
    J Perinat Med; 2022 Jun; 50(5):637. PubMed ID: 35487194
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to "The nature and severity of SARS-CoV-2 vaccines side effects are highly dependent on study design" and "Self-reported side effects following COVID-19 vaccination in athletes: Correspondence".
    Komici K; Verderosa S; D'Amico F; Guerra G
    Hum Vaccin Immunother; 2023 Aug; 19(2):2260534. PubMed ID: 37737129
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to 'Letter to the Editor: Acute hypersensitivity myocardial infarction (Kounis syndrome) and hypersensitivity myocarditis following COVID-19 vaccine vaccination'.
    Zhang AA; Chew NWS
    QJM; 2023 Feb; 116(1):83-84. PubMed ID: 35134209
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to: COVID-19 Vaccination in Patients who Develop COVID-19 After Cancer Surgery: Correspondence by Mungmunpuntipantip and Wiwanitkit.
    Verhagen NB; Kothari AN
    Ann Surg Oncol; 2023 Apr; 30(4):2109-2110. PubMed ID: 36707483
    [No Abstract]   [Full Text] [Related]  

  • 12. Cutaneous Rosai-Dorfman disease after Covid 19 vaccination treated with thalidomide.
    Grimaldi M; Perino F; Moretta G; Antonelli F; Paradisi A; Ricci F; Abeni D; Didona B; Fania L
    Dermatol Ther; 2022 Nov; 35(11):e15864. PubMed ID: 36175132
    [No Abstract]   [Full Text] [Related]  

  • 13. [Skin manifestations of COVID-19 and after COVID-19 vaccination].
    Reinhart M; Metze D; Braun SA
    Hautarzt; 2022 Jun; 73(6):434-441. PubMed ID: 35477785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the Self-reported After Events Following Immunization of COVID-19 Vaccines in Turkey and Bangladesh.
    Sultana A; Mim SR; Saha A; Yesmin F; Tahsin MR; Bahar NB; Fatema KR; Shahriar S; Prattay KMR; Rabbi F; Noushin F; Samodder M; Sadia QA; Ferdous J; Mamun MAH; Uddin MI; Akter T; Rahman MM; Sarker MMR; Kuddus MR; Aktar F; Chowdhury JA; Chowdhury AA; Kabir S; Büyüker SM; Rahman MS; Rahman MH; Amran MS
    Environ Sci Pollut Res Int; 2023 Apr; 30(16):47381-47393. PubMed ID: 36738411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of constitutional and dermatologic side effects between COVID-19 and non-COVID-19 vaccines: Review of a publicly available database of vaccine side effects.
    Cohen SR; Gao DX; Kahn JS; Rosmarin D
    J Am Acad Dermatol; 2022 Jan; 86(1):248-249. PubMed ID: 34592382
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe rhabdomyolysis and SARS-CoV-2 vaccination: a reply to the letter by Dr. Josef Finsterer.: Reply to Letter to the Editor regarding our report to Dr. Finsterer.
    Kamura Y; Matsue K
    Int J Infect Dis; 2022 Sep; 122():1005. PubMed ID: 35760377
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to: correspondence on "Herpes Zoster and Simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis​".
    Gringeri M; Battini V; Cammarata G; Mosini G; Guarnieri G; Leoni C; Pozzi M; Radice S; Clementi E; Carnovale C
    Expert Rev Vaccines; 2022 Aug; 21(8):1161-1162. PubMed ID: 35522022
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to fever, Covid-19 vaccination, and Brugada syndrome-Incidence and management: Correspondence.
    Santoro F; Crea P; El-Battrawy I; Brunetti ND
    J Cardiovasc Electrophysiol; 2022 Sep; 33(9):2122. PubMed ID: 35924484
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19 vaccination and inflammatory skin diseases.
    Martora F; Villani A; Battista T; Fabbrocini G; Potestio L
    J Cosmet Dermatol; 2023 Jan; 22(1):32-33. PubMed ID: 36156846
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to Letter to the Editor: Atypical Optic Neuritis After COVID-19 Vaccination: Response.
    Tugizova M; Siegel DT; Huang S; Su E; Subramanian PS; Beres S; Vora N
    J Neuroophthalmol; 2023 Mar; 43(1):e37-e38. PubMed ID: 35439209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.